NCT06772909

Brief Summary

To find out the prevalence of renal dysfunction in chronic liver disease patients who admitted to sohag university hospital

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 2, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 14, 2025

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

January 14, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

January 2, 2025

Last Update Submit

January 11, 2025

Conditions

Renal Dysfunction

Outcome Measures

Primary Outcomes (1)

  • prevalence of renal dysfunction in patients with chronic liver disease

    prevalence of renal dysfunction in patients with chronic liver disease

    during admission time at sohag university hospital

Interventions

No intervention (observational study)OTHER

no intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

prevalence of renal dysfunction in chronic liver disease patients who admitted to sohag university hospital

You may qualify if:

  • \- Data regarding demographic variables (age, weight, sex),
  • Evidence for chronic liver disease is defined by:
  • A compatible Clinical profile (signs of liver cell failure or reduced liver span) along with Biochemical (altered liver function tests, reversal of albumin globulin ratio, etc) or Sonographic evidence (altered echotexture of the liver) Diuretics will be withheld for 3 days before carrying out lab investigations.

You may not qualify if:

  • patients \>70 years
  • Known primary renal disease or obstructive uropathy
  • Diabetes mellitus
  • Hypertension

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Renal Insufficiency

Interventions

Observation

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Reham Hossam Mohamed Ahmed

CONTACT

+201098190338reham_hossam_post@med.sohag.edu.eg

Amal Khalifa Ahmed noureldin

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident doctor

Study Record Dates

First Submitted

January 2, 2025

First Posted

January 14, 2025

Study Start

January 1, 2025

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

January 14, 2025

Record last verified: 2025-01